Vancouver, British Columbia, Dec. 09, 2020 (GLOBE NEWSWIRE) -- The Global Cancer Imaging Systems Market is estimated to garner a valuation of USD 12.24 Billion by the year 2027, as per the latest report by Emergen Research. The cancer imaging systems industry is witnessing a surge in demand propelled by the rising incidences of cancer. Cancer plays a key role in the socio-economic growth across the globe and contributes significantly to the cost burden of disease. Around 1,806,590 cases of cancer were expected to be diagnosed in 2020 in the U.S. alone, and 606,520 deaths were predicted from the illness.
Technological development and increasing investments in cancer imaging are boosting the growth of the sector. In November 2019, Hologic, Inc., was granted approval for its 3DQuorum™ Imaging Technology, operating on Genius AI™, by the U.S. Food and Drug Administration (FDA). The technology functions alongside Hologic’s Clarity HD™ high-resolution imaging technology and assists radiologists in bringing about a 66.0% decrease in the tomosynthesis image volume. Advancements in the breast imaging system help create higher-resolution 3D images, greater workflow, and gives patients a better mammography experience, entailing low radiation dose.
Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report@ https://www.emergenresearch.com/request-sample-form/222
Key Highlights From The Report
ORDER NOW (Customized Report Delivered as per Your Specific Requirement)@ https://www.emergenresearch.com/select-license/222
Emergen Research has bifurcated the global cancer imaging systems market based on application, end-user, imaging system, and region:
To identify the key trends in the industry and read full summary click on the link: https://www.emergenresearch.com/industry-report/cancer-imaging-systems-market
Take a Look at our Related Reports:
In Silico Drug Discovery Market By Workflow (Discovery, Preclinical Tests, Clinical Trials), By Product (Consultancy as a Service, Software as a Service), By Type of Large Molecule, By End User (Contract Research Organizations, Pharmaceutical Industry), and By Region, Forecasts to 2027
Human Microbiome Modulators Market By Product (Prebiotics and Dietary Supplements, Probiotics and Creams, Drugs), By Application (Infections, Neurological Disorders, Cancers, Dermatological, Gastrointestinal, Metabolic), By Region Forecasts to 2027
Intelligent Drug Discovery Market By Offering (Software, Services), By Technology (Machine Learning, Other Technologies), By Application (Neurodegenerative Diseases, Metabolic Diseases, Immuno-Oncology), By End User (Contract Research Organizations), and By Region, Forecasts to 2027
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkdIn | Twitter | Blogs
Read Full Press Release@ https://www.emergenresearch.com/press-release/global-cancer-imaging-systems-market